| Albert Lanzillo, | |
|
309 E 2nd St, Pomona, CA 91766-1854 | |
| (909) 623-6116 | |
| Not Available |
| Full Name | Albert Lanzillo |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Location | 309 E 2nd St, Pomona, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083302541 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Albert Lanzillo, 3309 Falcon Ave, Signal Hill, CA 90755-4811 Ph: (717) 475-3175 | Albert Lanzillo, 309 E 2nd St, Pomona, CA 91766-1854 Ph: (909) 623-6116 |
News Archive
Pfizer Inc. announced today that it has completed the sale of its Nutrition business to Nestlé for $11.85 billion in cash, following the conclusion of the required regulatory process in most markets. In certain countries where completion will be delayed due to ongoing regulatory review, Pfizer will continue to operate the business on an interim basis.
Uveal melanoma, or UM, is a rare and deadly cancer of the eye, and the mortality rate has remained unimproved for 40 years. Half of the melanomas spread to other organs of the body, causing death in less than a year, so new treatments to preserve vision and prevent death are an urgent need.
Spherix Incorporated - an intellectual property development company committed to the fostering and monetization of intellectual property, today announced that the United States Patent & Trademark Office issued three patents to the Company in the month of August that are part of a standard essential family of patents.
Reuters reports on a study (.pdf) examining the use of drought-tolerant maize in 13 African countries, which was published on Thursday by the International Maize and Wheat Improvement Centre (CIMMYT) with input from several other food research institutes (Cocks, 8/26).
Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for tofacitinib (development code CP-690,550), an investigational novel, oral JAK inhibitor being studied for the treatment of adult patients with moderately to severely active rheumatoid arthritis.
› Verified 6 days ago
Nancy Irene Nielsen-brown, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 309 E 2nd St, Pomona, CA 91766 Phone: 909-469-5386 | |
Brittney Tunon, Physician Assistant Medicare: Medicare Enrolled Practice Location: 309 E 2nd St, Pomona, CA 91766 Phone: 703-955-6286 | |
Chau Minh Nguyen, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 309 E 2nd St, Pomona, CA 91766 Phone: 951-892-4858 | |
Mr. Cyrus Querol, P.A. Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1798 N Garey Ave, Pomona, CA 91767 Phone: 510-350-2698 Fax: 510-879-9084 | |
Joana Chan Lu, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 160 E Artesia St Ste 310, Pomona, CA 91767 Phone: 909-865-9520 Fax: 909-865-9650 | |
Mia Curtis, Physician Assistant Medicare: Medicare Enrolled Practice Location: 309 E 2nd St, Pomona, CA 91766 Phone: 909-623-6116 | |
Jayme Livingston, Physician Assistant Medicare: Medicare Enrolled Practice Location: 309 E 2nd St, Pomona, CA 91766 Phone: 480-688-3979 |